Treatment Simplification for People with HIV and Limited Treatment Options: Oral and Long-Acting Approaches

Purpose of Review To examine clinical complexities and emerging therapeutic strategies for people with HIV on complex multi-tablet regimens or with limited treatment options. Recent Findings While single-tablet regimens standardise modern care, 3–10% of individuals face multi-class resistance and complex regimens and have increased risk of potential complications. Newer oral agents and long-acting injectables offer promising pathways to treatment optimisation, reducing pill burden, and overcoming barriers to sustainable access. Summary Transitioning toward person-centred definitions and long-acting or simplified approaches is vital to mitigate chronic inflammation and improve clinical outcomes for heavily treatment-experienced individuals.

Authors

Institutions

Publication Details

Journal
Current HIV/AIDS Reports
Published
2026-11-21
DOI
https://doi.org/10.1007/s11904-026-00806-y
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Treatment Simplification for People with HIV and Limited Treatment Options: Oral and Long-Acting Approaches

Chloe M. Orkin, Oliver Mercer, Kyle Ring
Current HIV/AIDS Reports
HIV/AIDS drug development and treatment
article

Treatment Simplification for People with HIV and Limited Treatment Options: Oral and Long-Acting Approaches

Chloe M. Orkin, Oliver Mercer, Kyle Ring
article en

Abstract

Purpose of Review To examine clinical complexities and emerging therapeutic strategies for people with HIV on complex multi-tablet regimens or with limited treatment options. Recent Findings While single-tablet regimens standardise modern care, 3–10% of individuals face multi-class resistance and complex regimens and have increased risk of potential complications. Newer oral agents and long-acting injectables offer promising pathways to treatment optimisation, reducing pill burden, and overcoming barriers to sustainable access. Summary Transitioning toward person-centred definitions and long-acting or simplified approaches is vital to mitigate chronic inflammation and improve clinical outcomes for heavily treatment-experienced individuals.

Current HIV/AIDS ReportsVol. 23(1)
Queen Mary University of London (GB), Barts Health NHS Trust (GB), Royal London Hospital (GB), Blizard Institute (GB)
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon